YOFOTO - Unicorn Nest

YOFOTO

YOFOTO

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

About

RepliCel Life Sciences is amongst the various portfolio company of this fund. The average start-up age at the time of investment by this fund is 6-10. Among the most popular investment industries for the fund are Clinical Trials, Therapeutics. However, the fund’s focus is not limited to this, since there is 1 more area of investment.

The fund usually invests by oneself.

The most exits for the fund occurred in 2014. Typical investments for this fund are deals in the range of 5 - 10 millions dollars. The fund's activity peaked in 2018. The fund usually participates in less than 2 investment rounds per year.

Fund Activity

Operative

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: